Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | DTE Energy Company DTE |
Capital Research Global Investors | 17,261,121 7.600% |
17,261,121 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Stifel Financial Corp. SF |
Capital Research Global Investors | 5,974,206 5.800% |
5,974,206 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Vale S.A. VALE |
Capital Research Global Investors | 294,934,543 5.600% |
294,934,543 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Valvoline Inc. VVV |
Capital Research Global Investors | 11,814,917 6.400% |
151,680 (+1.30%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Vector Group Ltd. VGR |
Capital Research Global Investors | 18,062,052 8.400% |
18,062,052 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Everi Holdings Inc. EVRI |
Capital Research Global Investors | 7,094,959 8.300% |
7,094,959 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX |
Capital Research Global Investors | 2,605,753 8.800% |
162,839 (+6.67%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Vontier Corporation VNT |
Capital Research Global Investors | 9,226,395 5.500% |
9,226,395 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Sale |
2021-02-16 | 13G | ENDURANCE INTL GROUP HLDGS INC EIGI |
Capital Research Global Investors | 0 0.000% |
-11,304,955 (Position Closed) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | EOG Resources, Inc. EOG |
Capital Research Global Investors | 70,646,904 12.100% |
24,910,519 (+54.47%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Essent Group Ltd. ESNT |
Capital Research Global Investors | 712,000 0.600% |
712,000 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
Capital Research Global Investors | 7,261,901 11.000% |
899,206 (+14.13%) |
Filing History |
| 2021-02-16 1:16 pm Sale |
2021-02-16 | 13G | Six Flags Entertainment Corporation FUN |
Capital Research Global Investors | 0 0.000% |
-7,946,163 (Position Closed) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Stanley Black & Decker, Inc. SWK |
Capital Research Global Investors | 10,452,773 6.500% |
10,452,773 (New Position) |
Filing History |
| 2021-02-16 1:16 pm Sale |
2021-02-16 | 13G | CSX Corporation CSX |
Capital Research Global Investors | 156,321,348 6.800% |
-6,275,505 (-3.86%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Dayforce Inc DAY |
Capital Research Global Investors | 18,108,406 12.300% |
1,289,761 (+7.67%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Thor Industries, Inc. THO |
Capital Research Global Investors | 6,781,928 12.200% |
1,114,094 (+19.66%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | Wolfspeed, Inc. CREE |
Capital Research Global Investors | 13,517,839 12.300% |
2,607,339 (+23.90%) |
Filing History |
| 2021-02-16 1:16 pm Purchase |
2021-02-16 | 13G | TopBuild Corp. BLD |
Capital Research Global Investors | 2,586,731 7.800% |
2,586,731 (New Position) |
Filing History |
| 2021-02-10 12:30 pm Purchase |
2021-02-10 | 13G | Sarepta Therapeutics, Inc. SRPT |
Capital Research Global Investors | 8,024,130 10.200% |
287,382 (+3.71%) |
Filing History |